Gene · 3535
Papers1,872
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,872
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection. | Nat Commun | 2023 | 37322000 | PubTator, text mining | PubMed |
| Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer. | Ann Oncol | 2023 | 37302750 | PubTator, text mining | PubMed |
| Vaccine elicitation and structural basis for antibody protection against alphaviruses. | Cell | 2023 | 37295404 | PubTator, text mining | PubMed |
| Potent neutralizing broad-spectrum antibody against SARS-CoV-2 generated from dual-antigen-specific B cells from convalescents. | iScience | 2023 | 37288342 | PubTator, text mining | PubMed |
| Partial response to niraparib in combination with tislelizumab in a patient with metastatic undifferentiated tonsillar carcinoma: a case report and literature review. | Front Oncol | 2023 | 37274279 | PubTator, text mining | PubMed |
| Inborn errors of human B cell development, differentiation, and function. | J Exp Med | 2023 | 37273190 | PubTator, text mining | PubMed |
| Complete pathological response of hormone receptor positive invasive breast cancer in a patient with multiple myeloma treated with ixazomib. | Tumori | 2023 | 37265183 | PubTator, text mining | PubMed |
| Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection. | Immunity | 2023 | 37257450 | PubTator, text mining | PubMed |
| Krüppel-like factor 2: a central regulator of B cell differentiation and plasma cell homing. | Front Immunol | 2023 | 37251374 | PubTator, text mining | PubMed |
| Histological Analysis of Regenerative Properties in Human Glenoid Labral Regions. | Am J Sports Med | 2023 | 37235877 | PubTator, text mining | PubMed |
| Liquid biopsy-based monitoring of residual disease in multiple myeloma by analysis of the rearranged immunoglobulin genes-A feasibility study. | PLoS One | 2023 | 37235573 | PubTator, text mining | PubMed |
| Epstein-Barr virus: the molecular virology and the associated diseases. | Fujita Med J | 2023 | 37234394 | PubTator, text mining | PubMed |
| Liquid biopsies and minimal residual disease in lymphoid malignancies. | Front Oncol | 2023 | 37228488 | PubTator, text mining | PubMed |
| Crystal-storing histiocytosis and associated marginal zone lymphoma with extensive plasmacytic differentiation. | Clin Case Rep | 2023 | 37220513 | PubTator, text mining | PubMed |
| Reconstruction of a polyclonal ADCC antibody repertoire from an HIV-1 non-transmitting mother. | iScience | 2023 | 37216090 | PubTator, text mining | PubMed |
| Case report: Anterior mediastinal mass in a patient with pleural effusion and dyspnea. | Front Surg | 2023 | 37206341 | PubTator, text mining | PubMed |
| Large B-Cell Lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Concepts. | Cancers (Basel) | 2023 | 37190213 | PubTator, text mining | PubMed |
| Human gene and microbial analyses in rectal cancer complete responses to radiotherapy. | BJS Open | 2023 | 37161675 | PubTator, text mining | PubMed |
| Liquid biopsy in hematological malignancies: current and future applications. | Front Oncol | 2023 | 37152045 | PubTator, text mining | PubMed |
| Long non‑coding RNAs in multiple myeloma (Review). | Int J Oncol | 2023 | 37144499 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3535/papers?page=9